Market Cap (In USD)
58.14 Million
Revenue (In USD)
775.3 Thousand
Net Income (In USD)
-35.31 Million
Avg. Volume
130.87 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.43-1.23
- PE
- -
- EPS
- -
- Beta Value
- 1.103
- ISIN
- US9286611077
- CUSIP
- 928661107
- CIK
- 93314
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Cameron Reynolds MBA
- Employee Count
- -
- Website
- https://www.volition.com
- Ipo Date
- 2012-03-02
- Details
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
More Stocks
-
PERM
-
MANU
-
IGTI11Iguatemi S.A.
IGTI11
-
5603
-
RSHNRushNet, Inc.
RSHN
-
JSGI
-
VINDHYATELVindhya Telelinks Limited
VINDHYATEL
-
3280STrust Co.,Ltd.
3280